Companies: 10,795·Total market cap: $144.5T
European Biotech Acquisition Corp.

European Biotech Acquisition Corp.

EBACNASDAQFinancial Services
$11.19
$-0.52(-4.44%)
Market Cap$183500312
P/E Ratio—
52W High$14.1
52W Low$9.282
Overview

European Biotech Acquisition Corp. (EBAC) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

EBAC · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
No earnings history available.
No analyst estimates available for EBAC.

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: EBAC ends December

European Biotech Acquisition Corp. (EBAC) reports earnings quarterly as a NASDAQ-listed Shell Companies company. The next EBAC earnings date is expected around September 1, 2026.

Each quarter, investors track EBAC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EBAC revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EBAC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

EBAC earnings · 3 questions

European Biotech Acquisition Corp.'s next earnings report is expected around September 1, 2026. EBAC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EBAC historically reports after market close (AMC).

EBAC earnings datewhen is EBAC earningsEBAC next earnings datewhen does EBAC report earningsEBAC earnings calendar

▸ Source: FMP · European Biotech Acquisition Corp. SEC filings · US GAAP · European Biotech Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026